ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

NCI To Offer Compromise On Including “Chop-Like Elements” In CCOP, Agrees Consortia “Appropriate”

May 14, 1982

In Brief: Cancer Act renewal, Appropriations Bill Caught In Squeeze Between Conventions

August 1, 1980

DCT To Examine Groups’ Studies, Directions, Role in 2000 A.D. Goal

June 8, 1984

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996

In Brief: white House Names Phillip Sharp To NCAB; Shine Re-appointed As IOM President

September 27, 1996

NCI Virus Program Has “Important Extension of Virology” as New Approach To Etiology

April 23, 1976